16 results
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
4 Dec 23
NLS Pharmaceutics Announces Election of Additional Board Members
4:45pm
Hospitals), managing the tech transfer office for 16 years and creating 75 start-ups. Dr. Allouche Aknin is an expert and mentor at the Paris
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
4 Dec 23
Report of Foreign Private Issuer
4:00pm
and managed for 16 years, the Tech Transfer Office of AP-HP. 75 startups created.
Expert & mentor at the main Paris’s incubators, she represented French
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
20 Jul 23
Report of Foreign Private Issuer
4:06pm
the path to approval by supporting manufacturing, funding, equipment, processes, and people. Audrey serves as a subject matter expert in building regional
20-F
tmy9q9xh4h8w91
14 May 21
Annual report (foreign)
5:05pm
6-K
EX-99.1
rmqyq
6 Apr 21
Report of Foreign Private Issuer
9:30am
424B4
zh46ksuw
1 Feb 21
Prospectus supplement with pricing info
11:52am
F-1/A
zdwwfyw3lu
20 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
kis xn06vydc06sxm
17 Nov 20
Registration statement (foreign) (amended)
5:28pm
F-1/A
uv7zuj
16 Oct 20
Registration statement (foreign) (amended)
9:59pm
F-1/A
qoqaj4lox237mw gqg2
31 Aug 20
Registration statement (foreign) (amended)
9:26am
F-1
uzop5
28 Feb 20
Registration statement (foreign)
5:37pm
F-1
EX-10.14
o1r 1ixbpcomc
28 Feb 20
Registration statement (foreign)
5:37pm
DRS/A
kpto4oqxdk i6d7v2
20 Feb 20
Draft registration statement (amended)
12:00am
DRS
y6h1q 5btjd2d9cyq4b
18 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next